Company news
Ironwood Pharmaceuticals, Inc. news in 2020
Ironwood Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.
Ironwood Pharmaceuticals Appoints Jay P. Shepard to Board of Directors
December 2, 2020
Ironwood Pharmaceuticals to Present at the 29th Annual Credit Suisse Healthcare Conference
November 5, 2020
Ironwood Pharmaceuticals Reports Strong Third Quarter 2020 Results and Increases Full Year 2020 Financial Guidance
November 4, 2020
Ironwood Pharmaceuticals Appoints Alexander Denner, Ph.D., to Board of Directors
November 4, 2020
Ironwood Pharmaceuticals to Host Third Quarter 2020 Investor Update Call
October 21, 2020
Ironwood to Discontinue IW-3718 Development Program Following Results from Planned Efficacy Assessment
September 28, 2020
Ironwood Pharmaceuticals Reports Second Quarter 2020 Results; Delivered GAAP Net Income of $25 Million and Adjusted EBITDA of $33 Million
August 5, 2020
Ironwood Pharmaceuticals to Host Second Quarter 2020 Investor Update Call
July 22, 2020
Ironwood Announces Updates Designed to Strengthen IW-3718 Phase III Program for Refractory Gastroesophageal Reflux Disease (GERD)
July 20, 2020
Ironwood and AbbVie Report Top-line Phase II Data for MD-7246 in Patients with Abdominal Pain Associated with Irritable Bowel Syndrome with Diarrhea (IBS-D)
May 26, 2020
Ironwood Pharmaceuticals Reports First Quarter 2020 Results and Provides Update on Impact of COVID-19 Pandemic
May 5, 2020
Ironwood and Allergan Receive Notices of Allowance for Patent Applications Covering 72 mcg Dose of LINZESS® (linaclotide)
April 27, 2020
Ironwood Pharmaceuticals to Host First Quarter 2020 Investor Update Call
April 15, 2020
Ironwood Pharmaceuticals Provides Update on Impact of COVID-19
March 25, 2020
Ironwood Pharmaceuticals Announces Publication of Positive IW-3718 Phase IIb Data in Gastroenterology
February 25, 2020
Ironwood Pharmaceuticals to Present at Upcoming March Investor Conferences
February 24, 2020
Ironwood Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference
February 18, 2020
Ironwood Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2019 Results, Exceeding Full Year 2019 Guidance; Provides Full Year 2020 Guidance
February 12, 2020
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Investor Update Call
January 29, 2020
Ironwood and Allergan Announce Settlement with Teva Resolving LINZESS® (linaclotide) Patent Litigation
January 21, 2020
Ironwood and Allergan Announce Settlement Resolving LINZESS® (linaclotide) Patent Litigation
January 5, 2020
Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
January 1, 2020
Calls in 2020
Decks in 2020
- Q3 2020 Earnings Presentation
Earnings · 21 slides · Nov 5, 2020
- Q2 2020 Earnings Presentation
Earnings · 23 slides · Aug 6, 2020
- Corporate Update (July 2020)
Corporate update · 10 slides · Jul 21, 2020
- Q1 2020 Earnings Presentation
Earnings · 22 slides · May 6, 2020
- Barclays Global Healthcare Conference 2020
Conference · 20 slides · Mar 12, 2020
- 9th Annual SVB Leerink Global Healthcare Conference (February 2020)
Conference · 11 slides · Feb 25, 2020
- FY2019 Earnings Presentation
Earnings · 30 slides · Feb 13, 2020
- J.P. Morgan 38th Annual Healthcare Conference (January 2020)
Conference · 57 slides · Jan 13, 2020